Bingnan Yin

1.1k total citations
14 papers, 842 citations indexed

About

Bingnan Yin is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Bingnan Yin has authored 14 papers receiving a total of 842 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Immunology and 4 papers in Oncology. Recurrent topics in Bingnan Yin's work include Immunotherapy and Immune Responses (6 papers), vaccines and immunoinformatics approaches (2 papers) and Virus-based gene therapy research (2 papers). Bingnan Yin is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), vaccines and immunoinformatics approaches (2 papers) and Virus-based gene therapy research (2 papers). Bingnan Yin collaborates with scholars based in United States, China and Italy. Bingnan Yin's co-authors include Rong‐Fu Wang, Helen Y. Wang, Mingjun Wang, Gary L. Johanning, Kiera Rycaj, Feng Wang‐Johanning, Joshua B. Plummer, Kevin Lin, Changsheng Xing and Tianhao Duan and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Nature Cell Biology.

In The Last Decade

Bingnan Yin

14 papers receiving 830 citations

Peers

Countries citing papers authored by Bingnan Yin

Since Specialization

Citations

This map shows the geographic impact of Bingnan Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingnan Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingnan Yin more than expected).

Fields of papers citing papers by Bingnan Yin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingnan Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingnan Yin. The network helps show where Bingnan Yin may publish in the future.

Co-authorship network of co-authors of Bingnan Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Bingnan Yin. A scholar is included among the top collaborators of Bingnan Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bingnan Yin. Bingnan Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	ACE2-dependent and -independent SARS-CoV-2 entries dictate viral replication and inflammatory response during infection 2024 ·Nature Cell Biology ·Tianhao Duan, Changsheng Xing, (unknown), (unknown), Yang Du, Xin Liu, Yuzhou Hu, Qian Chen, Bingnan Yin, Helen Y. Wang, Rong‐Fu Wang	24
2	USP3 plays a critical role in the induction of innate immune tolerance 2023 ·EMBO Reports ·Tianhao Duan, (unknown), Yang Du, Changsheng Xing, Junjun Chu, (unknown), Xin Liu, Motao Zhu, Qian Chen, Bingnan Yin, Helen Y. Wang, Jun Cui, Rong‐Fu Wang	7
3	Development of a TCR-like antibody and chimeric antigen receptor against NY-ESO-1/HLA-A2 for cancer immunotherapy 2022 ·Journal for ImmunoTherapy of Cancer ·Xin Liu, Yixiang Xu, Wei Xiong, Bingnan Yin, Yuqian Huang, Junjun Chu, Changsheng Xing, Qian Chen, Yang Du, Tianhao Duan, Helen Y. Wang, Ningyan Zhang, John S. Yu, Zhiqiang An, Rong‐Fu Wang	33
4	Pharmacological inhibition of fatty acid synthesis blocks SARS-CoV-2 replication 2021 ·Nature Metabolism ·Junjun Chu, Changsheng Xing, Yang Du, Tianhao Duan, Siyao Liu, (unknown), (unknown), Jill Henley, Xin Liu, Qian Chen, Bingnan Yin, (unknown), Rong‐Fu Wang	88
5	Microbiota regulate innate immune signaling and protective immunity against cancer 2021 ·Cell Host & Microbe ·Changsheng Xing, Mingjun Wang, (unknown), Peng Tan, (unknown), Lang Chen, Motao Zhu, (unknown), Junjun Chu, Xiao Yu, Bingnan Yin, Jiahui Zhu, (unknown), Tianhao Duan, Helen Y. Wang, Rong‐Fu Wang	116
6	Beclin 2 negatively regulates innate immune signaling and tumor development 2020 ·Journal of Clinical Investigation ·Motao Zhu, Guangtong Deng, Peng Tan, Changsheng Xing, Cuiping Guan, Chongming Jiang, Yinlong Zhang, Bo Ning, Chaoran Li, Bingnan Yin, Kaifu Chen, Yuliang Zhao, Helen Y. Wang, Beth Levine, Guangjun Nie, Rong‐Fu Wang	20
7	JMJD3 regulates CD4+ T cell trafficking by targeting actin cytoskeleton regulatory gene Pdlim4 2019 ·Journal of Clinical Investigation ·(unknown), Qingtian Li, Jia Zou, Changsheng Xing, (unknown), Bingnan Yin, Junjun Chu, Jiaming Yu, Xin Liu, Helen Y. Wang, Rong‐Fu Wang	14
8	Downregulation of Human Endogenous Retrovirus Type K (HERV-K) Viral env RNA in Pancreatic Cancer Cells Decreases Cell Proliferation and Tumor Growth 2017 ·Clinical Cancer Research ·Ming Li, Laszlo Radvanyi, Bingnan Yin, Kiera Rycaj, Jia Li, (unknown), Kevin Lin, Yue Lu, Jianjun Shen, David Chang, Donghui Li, Gary L. Johanning, Feng Wang‐Johanning	98
9	Cytotoxicity of Human Endogenous Retrovirus K–Specific T Cells toward Autologous Ovarian Cancer Cells 2014 ·Clinical Cancer Research ·Kiera Rycaj, Joshua B. Plummer, Bingnan Yin, Ming Li, (unknown), Laszlo Radvanyi, Lois M. Ramondetta, Kevin Lin, Gary L. Johanning, Dean G. Tang, Feng Wang‐Johanning	82
10	Current Advances in T-Cell-Based Cancer Immunotherapy 2014 ·Immunotherapy ·Mingjun Wang, Bingnan Yin, Helen Y. Wang, Rong‐Fu Wang	117
11	Identification of Special AT-Rich Sequence Binding Protein 1 as a Novel Tumor Antigen Recognized by CD8+ T Cells: Implication for Cancer Immunotherapy 2013 ·PLoS ONE ·Mingjun Wang, Bingnan Yin, Satoko Matsueda, Lijuan Deng, (unknown), Wei Zhao, Jia Zou, Qingtian Li, Christopher P. Loo, Rong‐Fu Wang, Helen Y. Wang	9
12	Human endogenous retrovirus type K antibodies and mRNA as serum biomarkers of early‐stage breast cancer 2013 ·International Journal of Cancer ·Feng Wang‐Johanning, Ming Li, Francisco J. Esteva, Kenneth R. Hess, Bingnan Yin, Kiera Rycaj, Joshua B. Plummer, (unknown), Stefan Ambs, Gary L. Johanning	94
13	Immunotherapeutic Potential of Anti-Human Endogenous Retrovirus-K Envelope Protein Antibodies in Targeting Breast Tumors 2012 ·JNCI Journal of the National Cancer Institute ·Feng Wang‐Johanning, Kiera Rycaj, Joshua B. Plummer, Ming Li, Bingnan Yin, (unknown), (unknown), Jianjun Shen, Kevin Lin, Peisha Yan, Sharon A. Glynn, Tiffany H. Dorsey, Kelly K. Hunt, Stefan Ambs, Gary L. Johanning	127
14	Identification of Prostate-Specific G-Protein Coupled Receptor as a Tumor Antigen Recognized by CD8+ T Cells for Cancer Immunotherapy 2012 ·PLoS ONE ·Satoko Matsueda, Mingjun Wang, Jinsheng Weng, (unknown), Bingnan Yin, Jia Zou, Qingtian Li, Wei Zhao, Weiyi Peng, Xavier Legras, Christopher P. Loo, Rongfu Wang, Helen Y. Wang	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact